The variation in TSP1 levels with obesity progression suggests a potential pathogenic function for this glycoprotein in the cardiometabolic sequelae of obesity and insulin resistance before the menopausal transition. This evidence concerns the gene THBS1 and obesity due to melanocortin 4 receptor deficiency.